A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Part of paid clinical trials in Chandler, Arizona.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT06937229
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Agitation
- Alzheimer Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- KarXT — DRUGSpecified dose on specified days
- KarX-EC — DRUGSpecified dose on specified days
Study Details
The purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an immediate release (IR) capsule (KarXT) and xanomeline enteric capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 or CN012-0024.
Key Dates
- Start date
- Dec 2, 2025
- Status verified
- Jun 2026
- Primary completion
- Jun 22, 2029
- Completion
- Jul 20, 2029
Study Design
- Enrollment
- 600 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: KarXT+KarX-EC
Primary Outcome Measure
Number of Participants With Treatment Emergent Adverse Events (TEAEs) [ Time Frame: Up to approximately Week 30 ]
Central Contacts
- BMS Clinical Trials Contact Center www.BMSClinicalTrials.com, www.BMSStudyConnect.com855-907-3286
- First line of the email MUST contain NCT # and Site #.
Locations (48)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Local Institution - 2609 | Chandler | Arizona | 85224 | Site 2609 |
| Imaging Endpoints | Scottsdale | Arizona | 85258 | Nida Laurin, Site 1619 480-290-1547 |
| Local Institution - 1657 | Anaheim | California | 92805 | Site 1657 |
| Local Institution - 2620 | Canoga Park | California | 91303 | Site 2620 |
| Local Institution - 1637 | La Jolla | California | 92037 | Site 1637 |
| Local Institution - 2607 | Long Beach | California | 90805 | Site 2607 |
| Local Institution - 2625 | Long Beach | California | 90040 | Site 2625 |
| Local Institution - 2642 | Long Beach | California | 90807 | Site 2642 |
| Local Institution - 2613 | Pasadena | California | 91105 | Site 2613 |
| Local Institution - 1662 | Pomona | California | 91767 | Site 1662 |
| Local Institution - 1639 | Torrance | California | 90505 | Site 1639 |
| Local Institution - 1651 | Walnut Creek | California | 94596 | Site 1651 |
| Local Institution - 2602 | Bonita Springs | Florida | 34134-4154 | Site 2602 |
| Local Institution - 2626 | Hialeah | Florida | 33012 | Site 2626 |
| Local Institution - 1602 | Miami | Florida | 33122 | Site 1602 |
| Local Institution - 1618 | Miami | Florida | 33135 | Site 1618 |
| Nuovida Research Center | Miami | Florida | 33186 | Jorge Betancourt, MD, Site 1604 786-616-9853 |
| Local Institution - 1635 | Orlando | Florida | 32807 | Site 1635 |
| Progressive Medical Research | Port Orange | Florida | 32127 | Alexander White, Site 1612 386-304-7070 |
| IPTB Clinical Research | Tampa | Florida | 33629 | Jamie Fernandez, Site 2621 813-251-1800 |
| Hope Research Network - Miami | Virginia Gardens | Florida | 33166 | Jorge Jorge, Site 1609 786-681-4959 |
| Local Institution - 2611 | Atlanta | Georgia | 30328 | Site 2611 |
| Local Institution - 1636 | Gaithersburg | Maryland | 20877 | Site 1636 |
| Boston Center for Memory | Newton | Massachusetts | 02459 | Paul Solomon, Site 1638 413-281-0577 |
| Local Institution - 2615 | Worcester | Massachusetts | 01608 | Site 2615 |
| Local Institution - 2618 | Ann Arbor | Michigan | 48105 | Site 2618 |
| Local Institution - 1620 | Troy | Michigan | 48085 | Site 1620 |
| Local Institution - 2256 | Saint Paul | Minnesota | 55130 | Site 2256 |
| Local Institution - 2629 | Hattiesburg | Mississippi | 39402 | Site 2629 |
| Local Institution - 2628 | Las Vegas | Nevada | 89030 | Site 2628 |
| Redbird Research | Las Vegas | Nevada | 89119 | Jelena Kunovac, Site 1649 760-758-2222 |
| Local Institution - 1647 | West Long Branch | New Jersey | 07764 | Site 1647 |
| Local Institution - 1656 | New Windsor | New York | 12553 | Site 1656 |
| Local Institution - 2619 | Staten Island | New York | 10312 | Site 2619 |
| Local Institution - 1658 | Woodmere | New York | 11598-1739 | Site 1658 |
| West Clinical Research | Morehead City | North Carolina | 28557 | Patrick Morgante, Site 2608 252-515-0050 |
| Local Institution - 2617 | Blue Ash | Ohio | 45242 | Site 2617 |
| Local Institution - 1640 | Tulsa | Oklahoma | 74136 | Site 1640 |
| Epic Medical Research, LLC - Carrolton | Carrollton | Texas | 75006 | Andrea Brown, Site 2616 972-782-2405 |
| Local Institution - 2605 | Cypress | Texas | 77065 | Site 2605 |
| Local Institution - 1643 | El Paso | Texas | 79912 | Site 1643 |
| Local Institution - 2622 | Mesquite | Texas | 75150 | Site 2622 |
| Local Institution - 2623 | San Antonio | Texas | 78229 | Site 2623 |
| Pantheon Clinical Research, LLC | Bountiful | Utah | 84010 | Jackson Rhudy, Site 2612 801-200-3950 |
| Local Institution - 1646 | Bennington | Vermont | 05201-9810 | Site 1646 |
| Local Institution - 1644 | Seattle | Washington | 98122 | Site 1644 |
| Local Institution - 1654 | Spokane | Washington | 99201 | Site 1654 |
| Local Institution - 2610 | Milwaukee | Wisconsin | 53226 | Site 2610 |
Find similar trials in Chandler, AZ
By condition
By specialty
Related Studies
- GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) GenotypeEnrolling By Invitation · Banner Health · Phoenix, Arizona
- Neurologic Stem Cell Treatment StudyRecruiting · MD Stem Cells · Westport, Connecticut
- Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's DiseasePHASE4 · Recruiting · University of Texas at Austin · Austin, Texas
- Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's DiseaseEnrolling By Invitation · Wake Forest University Health Sciences · Winston-Salem, North Carolina